drugset / Trial / NCT02713178

Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty

NCT02713178

Phase 3 Completed 232 enrolled Pacira Pharmaceuticals, Inc
RandomizedParallel-groupTriple-blindTreatment

Summary

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study in 232 adult subjects undergoing primary unilateral TKA under general or spinal anesthesia.

Timeline

Start
2016-06-03
Primary completion
2017-06-30
Completion
2017-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 133 mg Other
Comparator Bupivacaine Other / unclassified 266 mg Other

Indications

No indication recorded.